Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report.
Med Mycol Case Rep
; 26: 42-43, 2019 Dec.
Article
en En
| MEDLINE
| ID: mdl-31667060
ABSTRACT
Mucormycosis are a group of infections that affect principally immunocompromised host and have a high mortality. Liposomal amphotericin B is the first-line treatment with combined surgical removal of the infectious focus. We report the case of 67-year-old man with idiopathic granulocytic aplasia and a cutaneous lesion caused by Rhizopus arrhizus treated with isavuconazole. Its safety profile and spectrum of activity make it an important therapeutic option.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Med Mycol Case Rep
Año:
2019
Tipo del documento:
Article
País de afiliación:
Italia